Clinical Trial

Prediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate whether integrating serum sodium levels and platelet count with the Albumin-Bilirubin (ALBI) score can improve the early prediction of spontaneous bacterial peritonitis (SBP) in cirrhotic patients with ascites. SBP is a common and potentially life-threatening complication of cirrhosis. Identifying at-risk patients early using simple, routine laboratory parameters could enhance risk stratification, guide monitoring strategies, and reduce associated morbidity and mortality. Participants will be Adult patients (≥18 years) with liver cirrhosis and ascites undergoing diagnostic paracentesis at Sohag University Hospital.
Trial Details
NCT Number NCT07116369
Lead Sponsor Sohag University
Conditions Spontaneous Bacterial Peritonitis
Enrollment 100 participants
Start Date 2025-08
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-11